Qilian International Holding Group Limited (BGM) - Total Liabilities
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has total liabilities worth $23.90 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Qilian International Holding Group Limit growing its equity to track the company's year-over-year net asset growth rate.
Qilian International Holding Group Limited - Total Liabilities Trend (2017–2024)
This chart illustrates how Qilian International Holding Group Limited's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Qilian International Holding Group Limit to measure how efficiently the company converts operating cash flow to free cash.
Qilian International Holding Group Limited Competitors by Total Liabilities
The table below lists competitors of Qilian International Holding Group Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OssDsign AB
ST:OSSD
|
Sweden | Skr78.64 Million |
|
Banxa Holdings Inc
V:BNXA
|
Canada | CA$28.40 Million |
|
Ardiden Ltd
AU:ADV
|
Australia | AU$17.89 Million |
|
Kuangli Photoelectric Technology Co Ltd
TW:6431
|
Taiwan | NT$607.01 Million |
|
Ai Energy Public Company Limited
BK:AIE
|
Thailand | ฿457.36 Million |
|
Ailleron S.A.
WAR:ALL
|
Poland | zł299.94 Million |
|
TransAct Technologies Incorporated
NASDAQ:TACT
|
USA | $15.60 Million |
|
ICAPE HOLDING EO -40
F:Z8J
|
Germany | €120.45 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Qilian International Holding Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Qilian International Holding Group Limit market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qilian International Holding Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qilian International Holding Group Limited (2017–2024)
The table below shows the annual total liabilities of Qilian International Holding Group Limited from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | $8.91 Million | +29.01% |
| 2023-09-30 | $6.91 Million | -27.78% |
| 2022-09-30 | $9.56 Million | -48.82% |
| 2021-09-30 | $18.68 Million | -3.20% |
| 2020-09-30 | $19.30 Million | +52.82% |
| 2019-09-30 | $12.63 Million | -19.13% |
| 2018-09-30 | $15.62 Million | -20.82% |
| 2017-09-30 | $19.73 Million | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more